Picture of Day One Biopharmaceuticals logo

DAWN — Day One Biopharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Day One Reports Q1 2022 Results And Provides Business Update

May 12 (Reuters) - Day One Biopharmaceuticals Inc  DAWN.O :
    * DAY ONE REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATE
    * DAY ONE BIOPHARMACEUTICALS INC - QTRLY LOSS PER SHARE
$0.48

Source text for Eikon:  ID:nGNX1YYp5T 
Further company coverage:  DAWN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Day One Biopharmaceuticals

See all news